Concepedia

Barbara Nuesslein‐Hildesheim

BN

22

Publications

1.6K

Citations

19

H-Index

1995

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Max Planck Institute for Heart and Lung Research

Genomics Institute of the Novartis Research Foundation

University of Toronto

Barbara Nuesslein‐Hildesheim is an author at Novartis (Switzerland) specializing in medicine, physiology, and health sciences.

Top concepts

Publications per year

1995–2023

22

Publications

22

The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate

P Gergely, Barbara Nuesslein‐Hildesheim, Danilo Guerini et al. · British Journal of Pharmacology · 2012 · 302 citations · Full text

Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator

Shifeng Pan, Nathanael S. Gray, Wenqi Gao et al. · ACS Medicinal Chemistry Letters · 2013 · 165 citations · Full text

, , +16

Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Daniela Angst, F. Gessier, Philipp Janser et al. · Journal of Medicinal Chemistry · 2020 · 149 citations · Full text

The circadian cycle of mPER clock gene products in the suprachiasmatic nucleus of the Siberian hamster encodes both daily and seasonal time

Barbara Nuesslein‐Hildesheim, John O’Brien, Francis J. P. Ebling et al. · European Journal of Neuroscience · 2000 · 144 citations

Leptin selectively increases energy expenditure of food-restricted lean mice

H J Döring, Knut Schwarzer, Barbara Nuesslein‐Hildesheim et al. · International Journal of Obesity · 1998 · 144 citations

, , +9

Rows per page

1–5 of 22